amlodipine has been researched along with Coronary Restenosis in 7 studies
Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
Coronary Restenosis: Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To review the efficacy and safety data of amlodipine and the angiotensin-receptor blockers (ARBs), focusing on heart failure, angina, percutaneous coronary intervention (PCI), and renal protection." | 4.81 | Amlodipine versus Angiotensin-receptor blockers for nonhypertension indications. ( Kalus, JS; White, CM, 2002) |
| "Only amlodipine was associated with clopidogrel poor-response." | 1.36 | The use of amlodipine, but not of P-glycoprotein inhibiting calcium channel blockers is associated with clopidogrel poor-response. ( Breet, NJ; de Boer, A; Deneer, VH; Hackeng, CM; Harmsze, AM; Klungel, OH; Robijns, K; Ruven, HJ; Ten Berg, JM; van Werkum, JW, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harmsze, AM | 1 |
| Robijns, K | 1 |
| van Werkum, JW | 1 |
| Breet, NJ | 1 |
| Hackeng, CM | 1 |
| Ten Berg, JM | 1 |
| Ruven, HJ | 1 |
| Klungel, OH | 1 |
| de Boer, A | 1 |
| Deneer, VH | 1 |
| Kalus, JS | 1 |
| White, CM | 1 |
| Dens, J | 1 |
| Desmet, W | 1 |
| Piessens, J | 1 |
| Yamazaki, T | 1 |
| Taniguchi, I | 1 |
| Kurusu, T | 1 |
| Shimazu, Y | 1 |
| Hashizume, Y | 1 |
| Takikawa, K | 1 |
| Kuwata, M | 1 |
| Onodera, T | 1 |
| Yoshikawa, M | 1 |
| Mochizuki, S | 1 |
| Rossetti, F | 1 |
| De Portu, S | 1 |
| Menditto, E | 1 |
| Scalone, L | 1 |
| Bustacchini, S | 1 |
| Cricelli, C | 1 |
| Mantovani, LG | 1 |
| Mancini, GB | 1 |
| Miller, ME | 1 |
| Evans, GW | 1 |
| Byington, R | 1 |
| Furberg, CD | 1 |
| Pitt, B | 1 |
| Thaulow, E | 1 |
| Jorgensen, B | 1 |
| Doyle, JJ | 1 |
| Casciano, R | 1 |
| Casciano, J | 1 |
| Kopp, Z | 1 |
| Arikian, S | 1 |
| Kim, R | 1 |
2 reviews available for amlodipine and Coronary Restenosis
| Article | Year |
|---|---|
Amlodipine versus Angiotensin-receptor blockers for nonhypertension indications.
Topics: Amlodipine; Angina Pectoris; Angiotensin Receptor Antagonists; Antihypertensive Agents; Coronary Res | 2002 |
An updated meta-analysis of calcium-channel blockers in the prevention of restenosis after coronary angioplasty.
Topics: Amlodipine; Angioplasty, Balloon, Coronary; Calcium Channel Blockers; Confidence Intervals; Coronary | 2003 |
2 trials available for amlodipine and Coronary Restenosis
| Article | Year |
|---|---|
Effect of amlodipine on vascular responses after coronary stenting compared with an angiotensin-converting enzyme inhibitor.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Coronary Angiography; Coronary Disease; | 2004 |
A pharmacoeconomic evaluation of results from the Coronary Angioplasty Amlodipine Restenosis Study (CAPARES) in Norway and Canada.
Topics: Amlodipine; Angioplasty, Balloon, Coronary; Calcium Channel Blockers; Canada; Coronary Artery Bypass | 2002 |
3 other studies available for amlodipine and Coronary Restenosis
| Article | Year |
|---|---|
The use of amlodipine, but not of P-glycoprotein inhibiting calcium channel blockers is associated with clopidogrel poor-response.
Topics: Aged; Amlodipine; Angioplasty; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood Platel | 2010 |
Pharmacoeconomic consequences of amlodipine besylate therapy in patients undergoing PTCA.
Topics: Amlodipine; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Restenosis; Cost-Benef | 2006 |
Post hoc analysis of coronary findings from the prospective randomized evaluation of the vascular effects of the Norvasc trial (PREVENT).
Topics: Amlodipine; Calcium Channel Blockers; Coronary Angiography; Coronary Artery Disease; Coronary Diseas | 2002 |